For the best experience of the website, please view this site in either Microsoft Edge, Google Chrome, Safari internet browsers rather than Internet Explorer.    

  • All
  • Explainers
  • Achievements
  • Events
  • News
Events

March 28, 2024

Lessons from a failed coeliac disease trial: a new way forwards?

Seminar 14, Beyond Insulin Seminar Series – Associate Professor Jason Tye-Din from WEHI will present ‘Lessons from a failed coeliac disease trial: a new way forwards?’

Read more
Events

February 23, 2024

Using Type 1 Diabetes Genetic Risk Scores for Prediction and Diagnosis of Type 1 Diabetes

Seminar 13, Beyond Insulin Seminar Series – Dr Maria Redondo from Baylor College of Medicine, Houston, Texas will provide an update on T1D Genetic Risk Scores for Prediction and Diagnosis of T1D

Read more
Achievements

November 23, 2023

Research breakthrough

December 2023

In a world-first, ATIC researchers lead by Professor’s Thomas Kay and Helen Thomas have shown that baricitinib, an immunotherapy treatment commonly used in rheumatoid arthritis, can delay the progression of type 1 diabetes…

Read more
Events

November 23, 2023

CD47 – more than just a receptor on islets

Seminar 12 in the Beyond Insulin Seminar Series will be a summary of the findings from a recent discovery in CD47 receptors and type 1 diabetes by Professor Natasha Rogers (Westmead Hospital).

Read more
Events

October 27, 2023

Checkpoint inhibitor related autoimmune diabetes: from bench to bedside

Seminar 11 in the Beyond Insulin Seminar Series will be an update on current literature and knowledge around checkpoint inhibitor related diabetes from Dr Linda Wu (Westmead Institute for Medical Research).

Read more
News

T1D RELAY – New clinical trial now open

September 2023

ATIC and The Royal Melbourne Hospital are now seeking people aged 8-45 years with recently diagnosed type 1 diabetes (within three months) for a new clinical trial of two disease-modifying medications rituximab-pvvr and abatacept, called T1D RELAY.

Read more
Events

September 21, 2023

Who killed my beta cells and why did they do it?

Seminar 10 of the Beyond Insulin Seminar Series features Associate Professor Stuart Mannering who will discuss one of the fundamental outstanding questions in the immunology of T1D – how and why does the immune system attack the insulin producing cells?

Read more
Events

July 27, 2023

Role of the gut microbiota in T1D

Seminar 9 of the Beyond Insulin Seminar Series features Associate Professor Emma Hamilton-Williams. A/Prof Hamilton-Williams will discuss results from a clinical trial that aimed to restore a ‘healthy’ gut microbiota in adults with type 1 diabetes.

Read more
News

All trial sites for the Nasal Insulin and Abatacept (IAA Trial) are now open

June 2023

For the first time in Australia, researchers will carry out a type 1 diabetes trial to test two different immune therapies in children and young adults who have been recently diagnosed with type 1 diabetes.

Read more
Events

April 28, 2023

Viral aetiology of type 1 diabetes

7th seminar in the ‘Beyond Insulin: Innovative research in T1D prevention and cure’ seminar series

Read more
Explainers

Verapamil in type 1 diabetes

March 2023

The human immune system works every minute of every day to keep the body healthy – through constant monitoring, and by tracking and destroying pathogens, such as disease-causing bacteria and viruses.

Read more
Events

March 23, 2023

Continuous glucose monitoring in children at risk of type 1 diabetes

6th seminar in the ‘Beyond Insulin: Innovative research in T1D prevention and cure’ seminar series

Read more
Events

February 22, 2023

ATIC Town Hall Forum – video now available

ATIC recently invited members of the type 1 diabetes community to learn more about ATIC – the first Australasian clinical trial collaborative set up to accelerate development and delivery of immunotherapy treatments.  

Read more
Events

February 24, 2023

Baricitinib in the Treatment of Alopecia Areata

5th seminar in the ‘Beyond Insulin: Innovative research in T1D prevention and cure’ seminar series

Read more
News

IAA clinical trial now open for recruitment

January 2023

ATIC is now seeking participants aged between 6 and 21 years with newly diagnosed type 1 diabetes for a ground-breaking Australian clinical trial.

Read more
News

Community Engagement Panel – calling for expressions of interest

November 2022

ATIC is seeking expressions of interest from members of the type 1 diabetes community who are interested in joining our Community Engagement Panel.

Read more
Events

October 28, 2022

Benchmarking cells for beta cell replacement therapies

3rd seminar in the ‘Beyond Insulin: Innovative research in T1D prevention and cure’ seminar series

Read more
Events

September 29, 2022

Harnessing T cell exhaustion to treat autoimmune disease

2nd seminar in the ‘Beyond Insulin: Innovative research in T1D prevention and cure’ seminar series

Read more
Events

August 26, 2022

New ATIC Seminar Series: commencing 26th August 2022

Introducing ATIC’s new seminar series ‘Beyond Insulin: Innovative research in T1D prevention and cure’. Join us for a new session each month!

Read more
Events

August 10, 2022

August ATIC launch at Australian Diabetes Congress

We’re very excited to be officially launching ATIC at the upcoming ADC 2022 in Brisbane.

Read more
News

ATIC Steering Committee meet for the first time

April 2022

Leading diabetes clinicians and researchers from across Australia gathered recently for the first meeting of the Australasian Type 1 Diabetes Immunotherapies Collaborative (ATIC) Steering Committee.

Read more
Explainers

Immunotherapy: harnessing our immune system against disease

March 2022

The human immune system works every minute of every day to keep the body healthy – through constant monitoring, and by tracking and destroying pathogens, such as disease-causing bacteria and viruses.

Read more
News

IMPACT trial commences in Australia

February 2022

In collaboration with Innodia, the ATIC network is leading IMPACT, a trial of a new medication called IMCY-0098 to determine whether it can preserve pancreas function in people with newly diagnosed type 1 diabetes.

Read more
Achievements

BANDIT trial filled

January 2022

Thanks to the generosity of the type 1 diabetes community, we have completed recruitment for the BANDIT trial.

Read more
News

Collaborative focused on immunotherapy in type 1 diabetes – ANZ first

January 2022

JDRF Australia has funded a first-of-its kind four-year collaboration, aimed at increasing the number of clinical trials available for Australians with type 1 diabetes.

Read more